Larry Jones, the information director of Johnson & Johnson Medtech, recently made the decision to leave his position after an impressive career of 35 years old within the company. This departure, announced with a certain emotion, marks the end of an era for the man who knew how to guide digital innovation within surgical solutions. In a message shared with his colleagues, he evokes this change not as a farewell, but as a simple ” see you soon “, hinting at new adventures on the horizon.

Larry Jones, the information director of Johnson & Johnson Medtech, announced his resignation after more than thirty-five years within the company. In his departure message, he stressed that it was not a farewell, but a simple “see you soon”. Jones will officially leave J&J Medtech on November 15. During his career, he has notably led the development of connectivity solutions for digital surgery and machine learning platforms. Prior to his current role, he was also the global IT director of the subsidiary Janssen Pharmaceuticals. In his thoughts on the future, he expressed his commitment to using technology for good and working towards global health equity.

Larry Jones, after an impressive career of more than 35 years old within Johnson & Johnson Medtech, recently decided to leave. His resignation took many collaborators and partners who worked alongside him by surprise. Through a message shared on LinkedIn, he expressed that it was not a farewell but rather a ” see you soon “, hinting at future projects, without disclosing the details.

A remarkable journey at J&J Medtech

During his tenure, Jones played a key role in the development of connectivity solutions for the digital surgery, integrating surgical robots and machine learning platforms. As he approaches retirement, he remains grateful to his colleagues, emphasizing the importance of innovation in the medical field. This departure marks a real transformation for the company, which will have to adapt to this transition.

The future after J&J Medtech

Although Jones has not yet specified his future plans, he did mention his commitment to the use of technology to move towards a equitable global health. In his message, he displayed a determination to continue to fight against chronic diseases, thus demonstrating a deep commitment to the mission he has defended for so many years. The world of medical and of innovation continues to evolve, and Larry Jones has been a central player in this change at J&J.